Quax PH - Search Results

1

Clinical applications of the urokinase receptor (uPAR) for cancer patients.

Boonstra MC, Verspaget HW, Ganesh S, Kubben FJ, Vahrmeijer AL, van de Velde CJ, Kuppen PJ, Quax PH, Sier CF. Boonstra MC, et al. Among authors: quax ph. Curr Pharm Des. 2011;17(19):1890-910. doi: 10.2174/138161211796718233. Curr Pharm Des. 2011. PMID: 21711239 Review.

2

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.

Quax PH, van Muijen GN, Weening-Verhoeff EJ, Lund LR, Danø K, Ruiter DJ, Verheijen JH. Quax PH, et al. J Cell Biol. 1991 Oct;115(1):191-9. doi: 10.1083/jcb.115.1.191. J Cell Biol. 1991. PMID: 1918136 Free PMC article.

3

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.

Sier CF, Verspaget HW, Griffioen G, Verheijen JH, Quax PH, Dooijewaard G, De Bruin PA, Lamers CB. Sier CF, et al. Among authors: quax ph. Gastroenterology. 1991 Dec;101(6):1522-8. doi: 10.1016/0016-5085(91)90387-z. Gastroenterology. 1991. PMID: 1955118

4

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.

Quax PH, van Leeuwen RT, Verspaget HW, Verheijen JH. Quax PH, et al. Cancer Res. 1990 Mar 1;50(5):1488-94. Cancer Res. 1990. PMID: 2105839

5

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.

de Bart AC, Quax PH, Löwik CW, Verheijen JH. de Bart AC, et al. Among authors: quax ph. J Bone Miner Res. 1995 Sep;10(9):1374-84. doi: 10.1002/jbmr.5650100915. J Bone Miner Res. 1995. PMID: 7502710 Free article.

6

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

Sier CF, Quax PH, Vloedgraven HJ, Verheijen JH, Griffioen G, Ganesh S, Lamers CB, Verspaget HW. Sier CF, et al. Among authors: quax ph. Invasion Metastasis. 1993;13(6):277-88. Invasion Metastasis. 1993. PMID: 7860221

7

Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.

Boxman IL, Quax PH, Löwik CW, Papapoulos SE, Verheijen J, Ponec M. Boxman IL, et al. Among authors: quax ph. J Invest Dermatol. 1995 Mar;104(3):374-8. doi: 10.1111/1523-1747.ep12665844. J Invest Dermatol. 1995. PMID: 7861005 Free article.

8

Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.

De Vries TJ, Mooy CM, Van Balken MR, Luyten GP, Quax PH, Verspaget HW, Weidle UH, Ruiter DJ, Van Muijen GN. De Vries TJ, et al. Among authors: quax ph. J Pathol. 1995 Jan;175(1):59-67. doi: 10.1002/path.1711750110. J Pathol. 1995. PMID: 7891228 Free article.

9

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.

Sier CF, Vloedgraven HJ, Ganesh S, Griffioen G, Quax PH, Verheijen JH, Dooijewaard G, Welvaart K, van de Velde CJ, Lamers CB, et al. Sier CF, et al. Among authors: quax ph. Gastroenterology. 1994 Nov;107(5):1449-56. doi: 10.1016/0016-5085(94)90549-5. Gastroenterology. 1994. PMID: 7926508

10

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

de Vries TJ, Quax PH, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, van Muijen GN. de Vries TJ, et al. Among authors: quax ph. Am J Pathol. 1994 Jan;144(1):70-81. Am J Pathol. 1994. PMID: 8291613 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page